Kraig Biocraft Labs
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce sp… Read more
Kraig Biocraft Labs (KBLB) - Total Assets
Latest total assets as of September 2025: $2.36 Million USD
Based on the latest financial reports, Kraig Biocraft Labs (KBLB) holds total assets worth $2.36 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kraig Biocraft Labs - Total Assets Trend (2009–2024)
This chart illustrates how Kraig Biocraft Labs’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Kraig Biocraft Labs - Asset Composition Analysis
Current Asset Composition (December 2024)
Kraig Biocraft Labs's total assets of $2.36 Million consist of 49.2% current assets and 50.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 44.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $6.88K | 0.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2009–2024)
This chart illustrates how Kraig Biocraft Labs's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kraig Biocraft Labs's current assets represent 49.2% of total assets in 2024, an increase from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 44.7% of total assets in 2024, down from 89.3% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 0.5% of total assets.
Kraig Biocraft Labs Competitors by Total Assets
Key competitors of Kraig Biocraft Labs based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel N.V
OTCQX:AKZOF
|
USA | $13.95 Billion |
|
YeSUN Tech Co.Ltd.
KQ:250930
|
Korea | ₩51.65 Billion |
|
Hangzhou Flariant Co Ltd
SHG:605566
|
China | CN¥2.55 Billion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
DL Holdings CO. LTD.
KO:000210
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
Kraig Biocraft Labs - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Kraig Biocraft Labs generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Kraig Biocraft Labs is currently not profitable relative to its asset base.
Kraig Biocraft Labs - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.16 | 0.13 | 0.11 |
| Quick Ratio | 0.16 | 0.13 | 0.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-8.54 Million | $ -8.10 Million | $ -6.63 Million |
Kraig Biocraft Labs - Advanced Valuation Insights
This section examines the relationship between Kraig Biocraft Labs's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 49.01 |
| Asset Growth Rate (YoY) | -53.4% |
| Total Assets | $1.51 Million |
| Market Capitalization | $73.78 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Kraig Biocraft Labs's assets at a significant premium ( 49.01x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Kraig Biocraft Labs's assets decreased by 53.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Kraig Biocraft Labs (2009–2024)
The table below shows the annual total assets of Kraig Biocraft Labs from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.51 Million | -53.44% |
| 2023-12-31 | $3.23 Million | -29.27% |
| 2022-12-31 | $4.57 Million | +51.26% |
| 2021-12-31 | $3.02 Million | +136.59% |
| 2020-12-31 | $1.28 Million | +70.11% |
| 2019-12-31 | $750.85K | +951.86% |
| 2018-12-31 | $71.38K | -37.66% |
| 2017-12-31 | $114.50K | -70.16% |
| 2016-12-31 | $383.66K | +25.82% |
| 2015-12-31 | $304.94K | -43.43% |
| 2014-12-31 | $539.00K | +73.31% |
| 2013-12-31 | $311.00K | +293.67% |
| 2012-12-31 | $79.00K | -64.57% |
| 2011-12-31 | $223.00K | +88.98% |
| 2010-12-31 | $118.00K | +321.43% |
| 2009-12-31 | $28.00K | -- |